GRAIL, Inc. GRAL
Updated: 12 Sep 2026
No signal published yet
We already track GRAIL and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow GRAIL, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow GRAIL free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, GRAIL reported its second-quarter 2026 financial results, showing a 26% year-over-year increase in total revenue to $44.7 million driven by higher Galleri test volumes. On August 7, 2026, the company announced that an FDA advisory committee meeting is anticipated in the fall of 2026 to review the Premarket Approval application for its Galleri test. Earlier in June 2026, GRAIL completed a $110 million equity financing with Samsung entities.
What Firelda Watch includes for GRAIL, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow GRAIL, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow GRAIL free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more